company profile -万博官网登录

home>about livzon>company profile
profile of zhuhai livzon diagnostics inc.
zhuhai livzon diagnostics inc. (hereinafter referred to as “livzon diagnostics”) was established in 1989. it is the first high-tech subsidiary of the listed company, livzon pharmaceutical group (a-share and h-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. livzon diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in china, a national high-tech enterprise.

livzon diagnostics has established many technical platforms such as enzyme-linked immunoassay, lateral flow chromatography, microorganisms testing, molecular testing, multiple-detection immunoassay, single-test chemiluminescence immunoassay, mast cell degranulation test for allergy, etc. meanwhile, livzon diagnostics also has fully automatic equipment development capability. the products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. therefore, livzon diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

zhuhai livzon diagnostics inc.  has equipped with its industrialization base for research and development, production and office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for research and development, which attracts professional elite talents from laboratory science, biological engineering and many other fields. zhuhai livzon diagnostics inc. owns 5 research and development teams spread in 3 research and development centers, which located in zhuhai, shanghai and suzhou city. the total research and development personnel accounted for nearly 20% , meanwhile the annual research and development investment reaches more than 10% of sales revenue. beside its independent research and development, zhuhai livzon diagnostics inc. has established long-term successful cooperation with many first-class international biomedical enterprises such as fujirebro from japan, siemens in germany, and mp company (usa), which has enhanced its comprehensive service capabilities. zhuhai livzon diagnostics inc. has won the title of honor as "national high-tech enterprises", "in vitro diagnostic engineering technology research center of guangdong province ", "guangdong provincial enterprise technology center", "innovative enterprises of guangdong province " and the national "post-doctoral research station". with a complete quality management system in production, zhuhai livzon diagnostics inc. has well achieved the national gmp certification, gsp certification and iso13485/iso9001 certification.
livzon overview
3
r&d centers
5
r&d teams
20%
scientific research personnel
50%
personnel with master degree
6000
r&d land area (m2)
作为中国ivd行业的先行者,丽珠试剂服务产品涵盖了传染性疾病、呼吸道感染、肿瘤标志物检测、药物浓度监测、自身免疫、过敏原检测及血液安全等众多领域,在呼吸道感染、传染性疾病、药物浓度监测等领域的市场占有率处于国内领先地位,多项产品市场占有率高达50%-90%。在2019年底中国爆发新型冠状病毒的第一时间,丽珠试剂便投入研发,迅速研制出新型冠状病毒(2019-ncov)igm / igg抗体检测试剂盒(胶体金法)产品,并获证上市,助力国内外疫情防控。
livzon diagnostics technology theme exhibition hall
focus on disease research · create new detection technology
网站地图